Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
78
NNNN Quote, Financials, Valuation and Earnings
Last price:
$41.44
Seasonality move
:
--
Day range:
$36.49 - $42.99
52-week range:
$5.00 - $55.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
164.94x
P/B ratio:
121.73x
Volume:
64.3K
Avg. volume:
33.1K
1-year change:
--
Market cap:
$1.5B
Revenue:
$8.9M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Anbio Biotechnology has -- downside to fair value with a price target of -- per share.
NNNN vs. S&P 500
-
Over the past 5 trading days, Anbio Biotechnology has overperformed the S&P 500 by 58.7% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Anbio Biotechnology does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Anbio Biotechnology has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Anbio Biotechnology reported revenues of --.
Earnings Growth
-
Anbio Biotechnology has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Anbio Biotechnology reported earnings per share of --.
Enterprise value:
2.1B
EV / Invested capital:
--
Price / LTM sales:
164.94x
EV / EBIT:
877.00x
EV / Revenue:
254.24x
PEG ratio (5yr expected):
--
EV / Free cash flow:
1,000.28x
Price / Operating cash flow:
648.26x
Enterprise value / EBITDA:
877.00x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-05 | 2024-12-05 | 2024-12-05 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $13.9M | $15.7M | $18.5M | |
| Total Assets | -- | -- | $14M | $15.8M | $18.9M | |
| Current Liabilities | -- | -- | $1.4M | $993.1K | $1.7M | |
| Total Liabilities | -- | -- | $1.4M | $993.1K | $1.7M | |
| Total Equity | -- | -- | $12.5M | $14.8M | $17.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-05 | 2024-12-05 | 2024-12-05 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
NNNN
Sector
Market Cap
$1.5B
--
Price % of 52-Week High
62.03%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$25.58
200-day SMA
Buy
Level
$24.00
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$24.01
Relative Strength Index (RSI14)
Buy
Level
71.71
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-27.218
50-day SMA
Buy
Level
$26.29
MACD (12, 26)
Buy
Level
0.77
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
--
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (2.185)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-4.4396)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
Stock Forecast FAQ
In the current month, NNNN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NNNN average analyst price target in the past 3 months is --.
-
Where Will Anbio Biotechnology Stock Be In 1 Year?
According to analysts, the consensus estimate is that Anbio Biotechnology share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Anbio Biotechnology?
Analysts are divided on their view about Anbio Biotechnology share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Anbio Biotechnology is a Sell and believe this share price will rise from its current level to --.
-
What Is Anbio Biotechnology's Price Target?
The price target for Anbio Biotechnology over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NNNN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Anbio Biotechnology is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NNNN?
You can purchase shares of Anbio Biotechnology via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Anbio Biotechnology shares.
-
What Is The Anbio Biotechnology Share Price Today?
Anbio Biotechnology was last trading at $41.44 per share. This represents the most recent stock quote for Anbio Biotechnology. Yesterday, Anbio Biotechnology closed at $34.52 per share.
-
How To Buy Anbio Biotechnology Stock Online?
In order to purchase Anbio Biotechnology stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get NNNN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NNNN
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
121.73x
--
Price / LTM sales
164.94x
--
Growth Metrics
NNNN
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
NNNN
Sector
Profitability FY 2024
$6.4M
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
5
Next Earnings Date
Dec
5
Estimated Next Earnings Date
Mar
6
Balance Sheet
NNNN
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$19.6M
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
64
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
